An implantable artificial substitute for a blood vessel intended to replace, bypass or shunt a portion of peripheral vasculature (excludes coronary and cerebral arteries) due to a disease, injury, or for haemodialysis access. It is made of synthetic polymer ma
| Company | Devices | Share |
|---|---|---|
| Vascutek Ltd | 1,718 | 61% |
| Intervascular Sas | 337 | 12% |
| W. L. Gore & Associates, Inc. | 169 | 6% |
| Bard Peripheral Vascular, Inc. | 153 | 5% |
| Maquet Cardiovascular Llc | 141 | 5% |
| William A. Cook Australia Pty. Ltd. | 101 | 4% |
| Atrium Medical Corporation | 82 | 3% |
| Cook Incorporated | 61 | 2% |
| Peca Labs, Inc. | 46 | 2% |
| Vascular Flow Technologies Ltd | 9 | 0% |
| Medtronic, Inc. | 6 | 0% |
| Phraxis Inc. | 1 | 0% |
Company = labeler of record on GUDID. 12 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| DSY | PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER | 3,041 |
| DSY | Prosthesis, Vascular Graft, Of 6mm And Greater Diameter | 480 |
| DYF | PROSTHESIS, VASCULAR GRAFT, OF LESS THEN 6MM DIAMETER | 407 |
| MAL | Graft, Vascular, Synthetic/Biologic Composite | 278 |
| MIH | SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | 246 |
| QSK | Hybrid stent graft, thoracic aortic lesion treatment | 120 |
Use these as the dimensions to specify in a tender line.
2,824 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Synthetic vascular graft, non-medicated", from 12 companies. The largest labeler is Vascutek Ltd with 61% of records.
DSY (PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER), DSY (Prosthesis, Vascular Graft, Of 6mm And Greater Diameter), DYF (PROSTHESIS, VASCULAR GRAFT, OF LESS THEN 6MM DIAMETER), MAL (Graft, Vascular, Synthetic/Biologic Composite)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add synthetic vascular graft, non-medicated to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.